Pohjois-Savon hyvinvointialue
- Address
- lock Available on a paid plan
Nervous System Diseases and Epilepsy Research
At Pohjois-Savon hyvinvointialue, clinical trials in Nervous System Diseases focus on conditions such as refractory focal onset epilepsy, Dravet syndrome, and developmental and epileptic encephalopathies. This research is aimed at evaluating new treatment options and understanding how better seizure control can improve daily life for patients.
- Testing new therapies for difficult-to-control seizures
- Studying treatments for rare childhood epilepsy syndromes
- Improving symptom control and quality of survival
These studies reflect a strong neurological profile at the Neurocenter, Department of Neurology, with a clear emphasis on better long-term outcomes.
Oncology and Hematology
Much of the trial activity at this site centers on Neoplasms, including acute lymphoblastic leukemia, acute myeloid leukemia, breast cancer, endometrial cancer, and several forms of lung, ovarian, and prostate cancer. The studies are designed to test new cancer treatments, compare them with current standards, and improve survival in both adult and pediatric patients.
- Evaluating targeted and immune-based cancer therapies
- Improving treatment for relapsed or high-risk blood cancers
- Comparing new approaches for advanced solid tumors
This broad oncology portfolio shows active work in both common and rare cancers, with several trials seeking better control of advanced disease.
Pediatric Oncology and Rare Cancers
The site also contributes to international studies in pediatric cancer, especially medulloblastoma, ependymoma, rhabdomyosarcoma, lymphoblastic lymphoma, and childhood leukemia. These trials aim to refine treatment strategies, improve cure rates, and reduce relapse risk in children and adolescents.
- Studying improved therapy for high-risk childhood brain tumors
- Testing treatment strategies for relapsed pediatric leukemia and lymphoma
- Supporting more precise risk-adapted care in young patients
The research emphasizes safer and more effective care for younger patients facing aggressive or rare malignancies.
Cardiovascular Diseases and Stroke Prevention
Trials in Cardiovascular Diseases include studies of coronary artery disease, valve disease, and prevention of ischemic stroke in patients at elevated vascular risk. The purpose of this work is to assess new treatments that may reduce major cardiovascular events and support better prevention after acute illness.
- Evaluating therapies for patients at high risk of heart attack or stroke
- Studying treatment options for refractory angina and severe coronary disease
- Improving prevention after ischemic stroke or transient ischemic attack
These studies combine prevention and symptom-focused care, highlighting an interest in both chronic cardiovascular management and event reduction.
Women's Health and Pregnancy-Related Research
Research in Female Urogenital Diseases and Pregnancy Complications includes studies in ovarian cancer, endometrial cancer, and labour pain. The trials are aimed at improving treatment effectiveness in gynecologic cancers and understanding the safety and impact of pain management during childbirth.
- Testing new approaches for advanced gynecologic cancers
- Evaluating cancer treatments for recurrent or metastatic disease
- Studying maternal and neonatal effects of labor analgesia
This area combines oncology and obstetric care, showing a practical focus on both cancer outcomes and maternal health.
Diagnostic and Therapeutic Techniques
Some trials at Pohjois-Savon hyvinvointialue explore new diagnostic and therapeutic techniques, including regenerative gene therapy, imaging review, and supportive care approaches. These studies are intended to improve how disease is assessed and how treatment decisions are made in complex conditions.
- Assessing new regenerative and gene-based treatment concepts
- Improving disease evaluation through centralized imaging review
- Exploring supportive care methods in intensive and surgical settings
Work in this field supports more precise care delivery and better decision-making across multiple specialties.
Infectious Disease, Metabolic Health, and Health Care Quality
The remaining trial portfolio includes studies in virus diseases, nutritional and metabolic diseases, and health care quality. These trials include vaccine research, prevention-focused studies, and evaluations of care delivery in acute and specialized settings.
- Testing vaccines and immune responses against viral infection
- Studying treatment strategies linked to metabolic and vascular risk
- Evaluating how care can be improved in hospital and intensive care environments
This mix of research areas shows a broad clinical trial environment that extends beyond cancer and neurology into prevention and health system improvement.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 7 therapeutic areas and 15 of 103 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 102 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 24 by active trials.
lock +23 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +13 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 107 other sites in Finland
Therapeutic Area Benchmark — Finland
Select a therapeutic area to compare against other sites in Finland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Finland
Market Share
Country: Finland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pohjois-Savon hyvinvointialue
lock Showing 1 of 46 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase III Randomised, Double-Blind, Placebo-Controlled, Multicentre Study of Durvalumab in Combination with Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib in Newly Diagnosed Advanced Ovarian Cancer Patients (DUO-O). | AstraZeneca AB | Phase III | Not Recruiting | Feb 2019 | Apr 2026 |
IMP list
lock Showing 1 of 103 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Vincristine Sulfate | 7 | Unknown | 2015-06-02 | 2021-11-05 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.